Immunology

Immunology Today—May 20, 2026

This week’s Immunology update highlights regulatory and clinical developments…


Cell_Gene_Therapy

Cell and Gene Therapy Today—May 14, 2026

This week’s Gene and Cell Therapy update highlights regulatory updates,…


Onco_background

Oncology Today—May 11, 2026

This week’s Oncology update highlights regulatory progress, late-stage clinical…


Onco_background

Oncology Today—April 20, 2026

This week’s Oncology update highlights regulatory progress, pivotal clinical…


Onco_background

Oncology Today—April 14, 2026

This week’s Oncology update highlights regulatory progress, pivotal clinical…


Rare Disease news

Rare Diseases Today—April 9, 2026

This week’s Rare Diseases update highlights regulatory momentum, late-stage…


Onco_background

Oncology Today—April 6, 2026

This week’s Oncology update highlights regulatory progress, late-stage clinical…


Onco_background

Oncology Today—March 9, 2026

This week’s Oncology update highlights regulatory approvals, reimbursement…


Onco_background

Oncology Today—February 9, 2026

This week's Oncology update , covers regulatory actions, late-stage clinical…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AstraZeneca buys remaining China rights to AbelZeta’s GPC3-armored CAR-T

Lucid Diligence Brief: AstraZeneca buys remaining China rights to AbelZeta’s…


Oncology News

Oncology Video Recap—January 19, 2026

In this week's Oncology update regulatory milestones and late-stage clinical…


ESMO GI 2025_Preview_by_LucidQuest

ESMO GI 2025 Preview: Key Gastrointestinal Oncology Highlights to Watch

ESMO GI 2025 at a glance Get ready for ESMO GI 2025 with LucidQuest’s…


Privacy Preference Center